Literature DB >> 10534617

In vivo analysis of Frat1 deficiency suggests compensatory activity of Frat3.

J Jonkers1, R van Amerongen, M van der Valk, E Robanus-Maandag, M Molenaar, O Destrée, A Berns.   

Abstract

The Frat1 gene was first identified as a proto-oncogene involved in progression of mouse T cell lymphomas. More recently, FRAT/GBP (GSK-3beta Binding Protein) family members have been recognized as critical components of the Wnt signal transduction pathway. In an attempt to gain more insight into the function of Frat1, we have generated Frat1-deficient mice in which most of the coding domain was replaced by a promoterless beta-galactosidase reporter gene. While the pattern of LacZ expression in Frat1(lacZ)/+ mice indicated Frat1 to be expressed in various neural and epithelial tissues, homozygous Frat1(lacZ) mice were apparently normal, healthy and fertile. Tissues of homozygous Frat1(lacZ) mice showed expression of a second mouse Frat gene, designated Frat3. The Frat1 and Frat3 proteins are structurally and functionally very similar, since both Frat1 and Frat3 are capable of inducing a secondary axis in Xenopus embryos. The overlapping expression patterns of Frat1 and Frat3 during murine embryogenesis suggest that the apparent dispensability of Frat1 for proper development may be due to the presence of a second mouse gene encoding a functional Frat protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534617     DOI: 10.1016/s0925-4773(99)00187-2

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  8 in total

1.  Frat is a phosphatidylinositol 3-kinase/Akt-regulated determinant of glycogen synthase kinase 3β subcellular localization in pluripotent cells.

Authors:  Matthew Bechard; Robert Trost; Amar M Singh; Stephen Dalton
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

2.  Silencing of FRAT1 by siRNA inhibits the proliferation of SGC7901 human gastric adenocarcinoma cells.

Authors:  Qinggong Yu; L U Shang; Hongbo Yu; Zirong Yang; Dekui Xu
Journal:  Biomed Rep       Date:  2016-01-11

3.  Frat is dispensable for canonical Wnt signaling in mammals.

Authors:  Renée van Amerongen; Martijn Nawijn; Jonathan Franca-Koh; John Zevenhoven; Hanneke van der Gulden; Jos Jonkers; Anton Berns
Journal:  Genes Dev       Date:  2005-01-28       Impact factor: 11.361

4.  siRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancer.

Authors:  Alix Bee; Daniel Brewer; Carol Beesley; Andrew Dodson; Shiva Forootan; Timothy Dickinson; Patricia Gerard; Brian Lane; Sheng Yao; Colin S Cooper; Mustafa B A Djamgoz; Christine M Gosden; Youqiang Ke; Christopher S Foster
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

5.  Frequently rearranged in advanced T‑cell lymphomas‑1 demonstrates oncogenic properties in prostate cancer.

Authors:  Wei Zhang; Hua Xiong; Yanmei Zou; Sanpeng Xu; Lanping Quan; Xianglin Yuan; Ningzhi Xu; Yihua Wang
Journal:  Mol Med Rep       Date:  2016-09-05       Impact factor: 2.952

6.  Knockdown of FRAT1 expression by RNA interference inhibits human glioblastoma cell growth, migration and invasion.

Authors:  Geng Guo; Dong Kuai; Sang Cai; Naizhao Xue; Yueting Liu; Jiehe Hao; Yimin Fan; Ji Jin; Xinggang Mao; Bolin Liu; Chengliang Zhong; Xiang Zhang; Yi Yue; Xiaodong Liu; Ning Ma; Yuhong Guo
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

7.  TMEM98 is a negative regulator of FRAT mediated Wnt/ß-catenin signalling.

Authors:  Tanne van der Wal; Jan-Paul Lambooij; Renée van Amerongen
Journal:  PLoS One       Date:  2020-01-21       Impact factor: 3.240

Review 8.  A Comprehensive Review of Genetically Engineered Mouse Models for Prader-Willi Syndrome Research.

Authors:  Delf-Magnus Kummerfeld; Carsten A Raabe; Juergen Brosius; Dingding Mo; Boris V Skryabin; Timofey S Rozhdestvensky
Journal:  Int J Mol Sci       Date:  2021-03-31       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.